Back to Nuveen, LLC Nuveen, LLC

TNXPTNXP
5 quarters

Position history for Nuveen, LLCNuveen, LLC's holdings in TONIX PHARMACEUTICALS HLDG C

Yes. Nuveen Investments holds 117,447 shares of TNXP (Tonix Pharmaceuticals), worth $1.5M, as of its Q2 2026 13F filing. It increased the position by 22,886 shares (+24.2%) from Q1 2026. Nuveen Investments has held TNXP since Q2 2025, across 5 quarterly 13F filings.

Current Value

$1.5M

Current Shares

117,447

Total Value Change

-$368,450

Total Shares Change

+65,555

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
117,447
+24.2%
$1.5M0.0%$12.76
31
2026-Q1
Increased
94,561
+1.2%
$1.3M0.0%$13.75
26
2025-Q4
Increased
93,402
+507.7%
$1.5M0.0%$15.62
41
2025-Q3
Decreased
15,369
-70.4%
$371,3150.0%$24.16
0
2025-Q2
New
51,892
-
$1.9M0.0%$35.98
36

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used